Precaution For Covid-19 Vaccination By Health Ministry of India
Precaution For Covid-19 Vaccination By Health Ministry of India
Image Source: Google Image
Reading Time: 3 Minutes Approx
In a letter to all or any of any states and Union territories, the ministry highlighted that under the emergency use authorization, coronavirus vaccination is indicated only for 18 years and above. If required, the COVID-19 vaccine and other vaccines should be separated by an interval of a minimum of 14 days.
Interchangeability of COVID-19 vaccines isn't permitted and pregnant and lactating women should not be administered the shots as they have not been a neighborhood of any anti-coronavirus vaccine clinical trial thus far, the health ministry said.
"Interchangeability of COVID-19 vaccines isn't permitted. The second dose should even be of an equivalent COVID-19 vaccine which was administered because the first dose," the letter was written by Manohar Agnani, Additional Secretary, Union health ministry said.
The ministry has listed precautions and contraindications for COVID-19 vaccination alongside a comparative factsheet for both the vaccines (Covishield and Covaxin) which contains information on vaccine platform, physical specifications, dosage, cold-chain storage requirements, contraindications, and minor AEFIs (adverse event following immunization). It said this information should be disseminated to program managers across all levels and thru them to cold-chain handlers and vaccinators for ready reference. Listing the contraindications, the health ministry cautioned against the administration of the vaccine in persons with a history of anaphylactic or allergy to a previous dose of COVID-19 vaccine, and in those with immediate or delayed onset anaphylaxis or allergy to vaccines or injectable therapies, pharmaceutical products, food items, among others.
According to the letter, just in case of persons having active symptoms of SARS-CoV-2 infection, coronavirus infected patients who are given anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma and acutely unwell and hospitalized patients thanks to any illness, the COVID-19 vaccination is to be deferred for four to eight weeks after recovery. "Pregnant and lactating women haven't been an area of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant or unsure of their pregnancy and lactating women shouldn't receive COVID-19 vaccine at this point," the letter stated. The vaccine should be administered with caution in persons with a history of any bleeding or coagulation disorder (like coagulation factor deficiency, coagulopathy, or platelet disorder, it said. "Following conditions aren't contraindicated for COVID-19 vaccines --persons with past history of SARS-CoV-2 infection and or RT-PCR positive illness, history of chronic diseases and morbidities and immuno-deficiency, HIV, patients on immune suppression thanks to any condition," the letter stated.
Prime Minister Narendra Modi will launch India's massive COVID-19 vaccination drive on January 16 via video conferencing, whilst adequate doses of Bharat Biotech's 'Covaxin' and Serum Institute's 'Covishield' vaccines are delivered across the country to all or any states and Union territories. The letter also mentions mild AEFIs following vaccination for both the vaccines. In the case of Covishied, some mild AEFI may occur like injection site tenderness, injection site pain, headache, fatigue, myalgia, malaise, pyrexia, chills and arthralgia, and nausea.
Some mild AEFIs just in case of Covaxin include injection site pain, headache, fatigue, fever, body ache, abdominal pain, nausea and vomiting, dizziness-giddiness, tremor, sweating, cold, cough, and injection site swelling. Paracetamol could also be wont to provide symptomatic relief from post-vaccination adverse reactions, the letter added.
Source :
Comments